Gregory D. Fairn
Critical illiness and injury
St. Michael Hospital
Dr. Greg Fairn is a Staff Scientist in the Keenan Research Centre for Biomedical Science at St. Michael’s Hospital. Dr. Fairn is trained in a variety of disciplines including Cell Biology, Immunology, Genetics and Biochemistry. He is an Assistant Professor at the University of Toronto in both the Department of Surgery and Biochemistry, as well as an Associate Member of the Institute of Medical Science, University of Toronto. He also holds appointments at the Hospital for Sick Children and the Institute for Biomedical Engineering and Science Technology (iBest), a partnership between St. Michael’s Hospital and Ryerson University. Finally, he is also a member of the recently established Canadian Consortium on Neurodegeneration in Aging (CCNA). His research interests are broad but tend to focus on novel aspects of lipid metabolism and cellular signaling in a variety of physiological settings. As such, he has published over 30 peer-reviewed articles, covering a variety of topics including innate immunity, cellular dynamics, lipid metabolism and chemical biology. Since beginning his lab at St. Michael’s Hospital in the summer of 2012, he has contributed to the training of over 20 students, post-doctoral fellows and visiting medical residents. Dr. Fairn serves on several academic and governmental review committees, including graduate student scholarship committees for the Canadian Institutes of Health Research (CIHR) and Alberta Innovates Health Solutions, respectively. He also is an editorial board member for the Journal Cellular Microbiology and serves as an ad hoc reviewer for a variety of other biochemical and cell biological publications. Dr. Fairn has received a New Investigator award from CIHR and an Early Researcher Award from the Government of Ontario to support the establishment of his laboratory. He also holds research grants from CIHR, CCNA and Natural Sciences and Engineering Research Council of Canada.
His research interests are broad but tend to focus on novel aspects of lipid metabolism and cellular signaling in a variety of physiological settings